Lung Cancer Screening Guidelines

Lehto, Rebecca H.
June 2014
Clinical Journal of Oncology Nursing;Jun2014, Vol. 18 Issue 3, p338
Academic Journal
Although the third leading cancer in incidence following breast and prostate, lung cancer is the principal cause of cancer death in the United States. The majority of lung cancer cases are detected at an advanced stage when surgical resection is no longer an option. Recent research has concluded that lung cancer screening with low-dose computed tomography for specific high-risk groups may reduce lung cancer mortality. Public awareness and the need for current information are growing regarding the state of the science relative to lung cancer screening for individuals at high risk for lung cancer. This article provides a historical perspective on the topic of lung cancer screening. The risks and benefits of screening are discussed, and current clinical practice guidelines are reviewed. Oncology nurses will need to be cognizant of the risks, benefits, and current guidelines related to lung cancer screening as they support patients and their families making informed decisions about personal health care.


Related Articles

  • Raising awareness of pressure ulcer prevention.  // Lamp;2010, Vol. 67 Issue 10, p8 

    The article discusses a decision which the New South Wales State Coroner, Magistrate Mary Jerram, made to ask the New South Wales Nurses' Association to promote awareness among its members to educate staff, patients and primary carers about pressure ulcer prevention.

  • Vaccinations 101: What Nurses Need to Know in 2015. Krischke, Megan Murdock // NurseZone Newsletter;Aug2015, p10 

    No abstract available.

  • Guidance on managing patients receiving erlotinib therapy. McPhelim, John; Borthwick, Diana; Guerin, Maria; Horne, Naomi; White, John // Cancer Nursing Practice;Nov2011, Vol. 10 Issue 9, p22 

    Five UK lung cancer nurse specialists met to arrive at a consensus on optimal follow-up and management strategies for patients with non-small cell lung cancer taking tyrosine kinase inhibitors, with specific reference to erlotinib. This relatively new treatment has an administration and toxicity...

  • Aiming for the Future. COGHILL, AMY S. // ONS Connect;Dec2013, Vol. 28 Issue 4, p36 

    The article focuses on the future of clinical trials of treatments of mutations. It states that Nancy Burns, manager for oncology research at UNC (University of North Carolina) Health Care in North Carolina, has highlighted several active clinical trials approved by the U.S. Food and Drug...

  • Bowel cancer.  // Nursing Standard;6/18/2014, Vol. 28 Issue 42, p22 

    The article reports on the prevalence of bowel cancer in Great Britain and discusses its signs and symptoms and causes and risk factors. A discussion of resources which offer additional information on bowel cancer, and of strategies that nurses can use to help their patients with bowel cancer,...

  • The RT as Lung Cancer Navigator. Edwards, Rita // AARC Times;Nov2015, Vol. 39 Issue 11, p23 

    The article discusses the risk of cigarette smoking-related diseases such as lung cancer. Topics discussed include risk of lung cancer such as damage of every organ in the body, guidelines published by the National Comprehensive Cancer Network (NCCN) for lung cancer screening, and the use of...

  • The Role of the Clinical Trial Nurse in Oklahoma. Barlow, Candida; Farrar, Helen M. // Oklahoma Nurse;Jun-Aug2013, Vol. 58 Issue 2, p4 

    No abstract available.

  • VTE Prevention: Development of an Institutional Protocol and the Nurse’s Role. Tietze, Mari; Gurley, Jalandria // MEDSURG Nursing;Sep/Oct2014, Vol. 23 Issue 5, p331 

    Venous thromboembolism (VTE), including the combined diseases of deep vein thrombosis and pulmonary embolism, is a significant health problem that affects mortality, morbidity, and resource expenditure. Multiple guidelines have been formulated to address this condition, but broad implementation...

  • We can all help reduce the resistance threat. Gallagher, Rose // Nursing Standard;11/13/2013, Vol. 28 Issue 11, p29 

    Diminishing effectiveness of antibiotics is a threat that nurses can tackle, says Rose Gallagher.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics